See more : PharmaCom BioVet, Inc. (PHMB) Income Statement Analysis – Financial Results
Complete financial analysis of Chen Nan Iron Wire Co.,Ltd (2071.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Chen Nan Iron Wire Co.,Ltd, a leading company in the Manufacturing – Tools & Accessories industry within the Industrials sector.
- AudioEye, Inc. (AEYE) Income Statement Analysis – Financial Results
- St. Modwen Properties Limited (1IG.F) Income Statement Analysis – Financial Results
- PostNL N.V. (PSTNY) Income Statement Analysis – Financial Results
- Alvopetro Energy Ltd. (ALV.V) Income Statement Analysis – Financial Results
- China Pioneer Pharma Holdings Limited (1345.HK) Income Statement Analysis – Financial Results
Chen Nan Iron Wire Co.,Ltd (2071.TWO)
About Chen Nan Iron Wire Co.,Ltd
Chen Nan Iron Wire Co.,Ltd manufactures and exports various kinds of fasteners and steel wires in Taiwan. It offers self drilling, chipboard, roofing, drywall, self tapping, collated, concrete, decking, wood, furniture, window, stainless steel, machine, set, trilobular thread forming, socket cap, SEMS, and nail screws; carriage, flange, hex, and lag bolts; hex flange, cage, hex, wing, nylon, square, dome cap, and panel nuts; bonding, external tooth lock, flat, internal tooth lock, spring lock, and umbrella washers; alloy, stainless steel, and carbon steel wires; and nails, hose clamps, and rivets, as well as specialty screws. The company exports its products to Europe, the United States of America, Australia, New Zealand, Asia, and the Middle East. Chen Nan Iron Wire Co.,Ltd was founded in 1992 and is based in Kaohsiung City, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 1.39B | 2.08B | 1.82B | 1.83B | 0.00 |
| Cost of Revenue | 1.10B | 1.56B | 1.52B | 1.69B | 0.00 |
| Gross Profit | 292.46M | 519.97M | 291.30M | 132.63M | 0.00 |
| Gross Profit Ratio | 21.04% | 24.97% | 16.05% | 7.27% | 0.00% |
| Research & Development | 4.99M | 4.38M | 3.65M | 3.70M | 0.00 |
| General & Administrative | 59.35M | 70.42M | 74.31M | 58.50M | 0.00 |
| Selling & Marketing | 36.62M | 75.76M | 74.06M | 59.22M | 0.00 |
| SG&A | 95.98M | 146.18M | 148.37M | 117.72M | 0.00 |
| Other Expenses | 0.00 | 33.42M | 48.53M | -33.77M | 0.00 |
| Operating Expenses | 104.26M | 150.56M | 152.02M | 121.43M | 0.00 |
| Cost & Expenses | 1.20B | 1.71B | 1.68B | 1.81B | 0.00 |
| Interest Income | 1.73M | 403.00K | 263.00K | 718.00K | 558.00K |
| Interest Expense | 27.89M | 33.37M | 33.29M | 34.69M | 35.93M |
| Depreciation & Amortization | 85.97M | 84.24M | 83.68M | 83.15M | 0.00 |
| EBITDA | 285.61M | 487.48M | 270.74M | 58.91M | 109.74M |
| EBITDA Ratio | 20.55% | 23.41% | 14.97% | 3.36% | 0.00% |
| Operating Income | 191.50M | 403.23M | 188.07M | -21.85M | 0.00 |
| Operating Income Ratio | 13.78% | 19.36% | 10.36% | -1.20% | 0.00% |
| Total Other Income/Expenses | -19.36M | -28.42M | -33.90M | -70.13M | -27.12M |
| Income Before Tax | 172.14M | 374.82M | 154.17M | -58.93M | 0.00 |
| Income Before Tax Ratio | 12.39% | 18.00% | 8.49% | -3.23% | 0.00% |
| Income Tax Expense | 40.63M | 79.78M | 22.84M | -13.59M | 4.95M |
| Net Income | 131.51M | 295.04M | 131.32M | -45.34M | -4.95M |
| Net Income Ratio | 9.46% | 14.17% | 7.23% | -2.48% | 0.00% |
| EPS | 1.97 | 5.32 | 2.29 | -0.79 | -0.09 |
| EPS Diluted | 1.98 | 5.30 | 2.28 | -0.79 | -0.09 |
| Weighted Avg Shares Out | 66.62M | 55.44M | 57.45M | 57.45M | 56.50M |
| Weighted Avg Shares Out (Dil) | 66.54M | 55.65M | 57.62M | 57.45M | 56.50M |
Source: https://incomestatements.info
Category: Stock Reports